| Is there a cure for my Barrett's esophagus?
|
|
Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. Jama 1998; 280(20):1747-51. |
|
Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993; 104(6):1686-91. |
|
Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. American Journal Of Surgical Pathology 1998; 22(2):239-45. |
|
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. The New England Journal of Medicine 2002; 346(15):1128-37. |
|
Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation [see comments]. American Journal Of Gastroenterology 1998; 93(10):1810-5. |
|
Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313(14):857-9. |
|
Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. American Journal of Gastroenterology 1997; 92(2):212-5. |
| El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A,
Sampliner RE. Proton pump imhibitors are associated with reduced
incidence of dysplasia in Barrett's esophagus. American Journal of
Gastroenterology 2004;99:1877-1883. |
|
Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc 1999; 50(2):229-40. |
|
Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96(5 Pt 1):1249-56. |
| Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC.
Proton-pump inhibitor therapy and the development of dysplasia in
patients with Barrett's esophagus. MJA 2004;180:387-391. |
|
Koelz H. GERD: Nonoperative treatment: Inhibition of acid secretion in gastroesophageal reflux disease. In: Bchler MW FE, Klaiber Ch, Krhenbhl L, ed. Gastroesophageal Reflux Disease (GERD): Back to Surgery? Progress in Surgery, vol. 23, 1997; 71-82. |
|
Levine DS, Reid BJ. Endoscopic Diagnosis of Esophageal Neoplasms. Gastrointestinal Tumors 1992; 2(3):395-413. |
|
Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32(12):1441-6. |
|
O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. American Journal of Gastroenterology 1999; 94(8):2037-42. |
|
Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett's esophagus. Dig Dis Sci 1989; 34(9):1336-9. |
|
Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointestinal Endoscopy 1999; 49(1):1-7. |
| Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy
with porfimer sodium for ablation of high-grade dysplasia in
Barrett's esophagus: international, partially blinded, randomized
phase III trial. Gastrointestinal Endoscopy, 2005,62(4);488-498. |
|
Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998; 2(2):186-92. |
|
Rantanen TK, Salo JA, Salminen JT, Kellokumpu IH. Functional outcome after laparoscopic or open Nissen fundoplication: a follow-up study. Archives Of Surgery 1999; 134(3):240-4. |
|
Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988; 75(8):760-3. |
| Sampliner RE. Managing Barrett's esophagus: What is new in
2005? Diseases of the Esophagus 2005; 18: 17-20. |
|
Sampliner RE, . Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. The American Journal of Gastroenterology 2002; 97(8):1888-95. |
|
Sampliner RE, Fass R. Partial regression of Barrett's esophagus--an inadequate endpoint. Am J Gastroenterol 1993; 88(12):2092-4. |
|
Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996; 44(5):532-5. |
|
Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89(10):1844-8. |
|
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93(7):1028-32. |
|
Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O_Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120(7):1607-19. |
|
Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Squamous islands in Barrett's esophagus: what lies underneath? American Journal of Gastroenterology 1998; 93(3):332-5. |
|
Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93(7):1033-6. |
|
Sontag SJ, Schnell TG, Chejfec G, Kurucar C, Karpf J, Levine G. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Alimentary Pharmacology And Therapeutics 1997; 11(1):147-56. |
|
Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984; 87(4):927-33. |
|
Van Laethem JL, Cremer M, Peny MO, Delhaye M, Devire J. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results [see comments]. Gut 1998; 43(6):747-51. |
|
Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A, al e. A comparison of five maintenance therapies for reflux esophagitis [see comments]. New England Journal Of Medicine 1995; 333(17):1106-10. |
|
Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 1999; 49(3 Pt 2):S20-3. |
|
Weston A, Badr A, Hassanein R. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. American Journal of Gastroenterology 1999; 94(12):3413-3419. |
